U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: July 9-15, 2023
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: July 9-15, 2023

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Robert M. Califf, M.D., MACC, Commissioner for Food and Drugs

Event Date: 07/10/2023
Location: Virtual
Subject: Supply Chain Resiliency
FDA Participant/Group: MICHELLE ADAMS; ANDREW ZACHER; HILARY MARSTON;
Non FDA Participant/Group: Robert Mauch, Steve Collis (AmerisourceBergen);

Event Date: 07/10/2023
Location: Virtual
Subject: Supply Chain Resiliency
FDA Participant/Group: MICHELLE ADAMS; HILARY MARSTON; ANDREW ZACHER;
Non FDA Participant/Group: Christine Baeder, Eric Couture, Michael Brzica, Sven Dethlefs (Teva Pharmaceuticals);

Event Date: 07/10/2023
Location: Virtual
Subject: Supply Chain Resiliency
FDA Participant/Group: HILARY MARSTON; ANDREW ZACHER; MICHELLE ADAMS;
Non FDA Participant/Group: Craig Cowman, Martha Russell, Rebecca McGrath (Cardinal Health);

Event Date: 07/10/2023
Location: Virtual
Subject: Supply Chain Resiliency
FDA Participant/Group: MICHELLE ADAMS; ANDREW ZACHER; HILARY MARSTON;
Non FDA Participant/Group: Brian Hoffman, Julie Hill, Michael Balog, Steve Weiss (Hikma);

Event Date: 07/10/2023
Location: Silver Spring, MD
Subject: Type 1 Diabetes Research and Therapies
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several members of the Juvenile Diabetes Research Foundation (JDRF) Children's Congress

Event Date: 07/10/2023
Location: Virtual
Subject: Regan Udall Foundation Evidence Generation Roundtable
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Government, academia, and industry

Event Date: 07/11/2023
Location: Virtual
Subject: Supply Chain Resiliency
FDA Participant/Group: ANDREW ZACHER; HILARY MARSTON; MICHELLE ADAMS;
Non FDA Participant/Group: Alan Santos, Barbara Rowland, Christine Menendez, Gene Cavacini, Peter Slone (McKesson);

Event Date: 07/12/2023
Location: Virtual
Subject: 24th Annual Bank of America Health Care Policy Conference
FDA Participant/Group: BETH FRITSCH;
Non FDA Participant/Group: Industry and government

Event Date: 07/12/2023
Location: Washington, DC
Subject: Pharmaceutical Research and Manufacturers of America (PhRMA), FDA, and Biomedical Research Committee Meeting
FDA Participant/Group: DAYLE CRISTINZIO;
Non FDA Participant/Group: Industry and government

Event Date: 07/13/2023
Location: Virtual
Subject: Oncologic Drug Shortages
FDA Participant/Group: HILARY MARSTON; RICHARD PAZDUR; ANDREW ZACHER;
Non FDA Participant/Group: Government and several National Cancer Institute designated cancer centers

Official Name: Janet Woodcock, M.D., Principal Deputy Commissioner

Event Date: 07/10/2023
Location: Oxford, UK
Subject: International Pandemic Sciences Conference 2023 - Making the Exceptional Routine; Speaker: Clinical Evaluation of Interventions In an Emergency: Lessons Learned From the Pandemic
FDA Participant/Group: N/A
Non FDA Participant/Group: Academia, industry, policy, and other stakeholders

Official Name: Andi Lipstein Fristedt, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

Event Date: 07/10/2023
Location: Virtual
Subject: Signing Ceremony for Confidentiality Commitment
FDA Participant/Group: KAREN RILEY, STACY OUELLETTE, FAZILA SHAKIR, ANTONY RIZKALLA
Non FDA Participant/Group: Pamuji Lestari (Indonesian Fish Quarantine and Inspection Agency (FQIA));

Event Date: 07/11/2023
Location: Washington, D.C.
Subject: National Committee on U.S. and China Relations, Track II Dialog on Healthcare Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Representatives of the Track II Dialog on Healthcare

Official Name: Carol Cave, Acting Associate Commissioner for Regulatory Affairs

Event Date: 07/14/2023
Location: Virtual
Subject: Risk Based Framework
FDA Participant/Group: CONRAD CHOINIERE; SARAH LYNCH;
Non FDA Participant/Group: Steve Hanway (Consumer Product Safety Commission);

Official Name: Heidi Rebello, Acting Associate Commissioner for External Affairs

No Significant Event

Official Name: Namandjé N. Bumpus, Ph.D., Chief Scientist

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

Event Date: 07/11/2023
Location: Washington Marriott Washington, DC
Subject: Friends of Cancer Research (FCR) Public Meeting, Establishing Evidence: New Advancements Using ctDNA; Keynote Panel
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Academia, healthcare, and other stakeholders

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 07/13/2023
Location: Washington, DC
Subject: American Orthopaedic Society for Sports Medicine 2023 Annual Meeting; Speaker: FDA’s Regenerative Medicine Framework
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, research, and academic stakeholders

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

Event Date: 07/13/2023
Location: Silver Spring, MD
Subject: Remanufacturing
FDA Participant/Group: WILLIAM MAISEL;
Non FDA Participant/Group: Alexander Hecht, Jeffrey Lersch, Richard Santora (Karl Storz);

Official Name: Donald Prater, Acting Director, Center for Food Safety and Applied Nutrition

Event Date: 07/13/2023
Location: Virtual
Subject: Safe Food Coalition; Human Foods Program Update, Upcoming Recall Regulations Stakeholder Engagement, Daily Harvest Crumbles Study and Vitro Implications
FDA Participant/Group: KARI BARRETT; CHRISTOPHER WALDROP; CHARLOTTE CHRISTIN; JANESIA ROBBS; JEFFREY FARRAR; TIMOTHY JACKSON; DOUGLAS STEARN; SUZANNE ROOSEN; KRISTI MULDOON JACOBS; VINETTA HOWARD KING;
Non FDA Participant/Group: Jaydee Hanson (Center for Food Safety); Michael Hansen (Consumer Reports); Mitzi Baum (STOP Foodborne Illness); Patricia Buck; Vanessa Coffman (Center for Foodborne Illness Research and Prevention); Sarah Sorscher (Center for Science in the Public Interest );

Official Name: Brian King, Ph.D., Director, Center for Tobacco Products

Event Date: 07/11/2023
Location: Virtual
Subject: Introductory Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several representatives from We Card

Event Date: 07/14/2023
Location: Virtual
Subject: Webinar; Broad Priorities of CTP and the Tobacco Online Policy Seminar (TOPS)
FDA Participant/Group: N/A
Non FDA Participant/Group: Several representatives from Tobacco Online Policy Seminar (TOPS)

Official Name: Tracey H. Forfa, J.D., Director, Center for Veterinary Medicine

No Significant Event

Official Name: Tucker Patterson, Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Mark Raza, J.D., Chief Counsel

No Significant Event

 

Back to Top